Use of a Reproductive Life Planning Tool at the Pediatric Well-Baby Visit With Postpartum Women

NCT03448289 | Completed

• 2 other identifiers: 2017-10091R03HS025265-01A1
• Study Type: interventional
• Target: 129
• Locations: 1 country
• Sites: 1

Brief Summary

Improved access to timely health care and contraception in the postpartum (PP) period is needed to reduce unintended pregnancies and help women achieve desired birth spacing. While the routine 6-week visit has historically been considered the place for women to discuss and receive contraception, many women, particularly low-income women, do not attend the postpartum visit. A novel approach to increasing receipt of PP care and contraception is the adoption of a reproductive life planning tool. Explorations of the use of a self-administered Reproductive Life Plan Tool (RLPT) by pediatricians in the context of the Well-Baby Visit (WBV) with postpartum mothers, holds great promise. The objective of this study is to determine whether use of a simple self-administered Reproductive Life Plan Tool at the 2-month WBV increases the proportion of postpartum women receiving woman's health care and contraception at 6-months PP, compared to women not exposed to such an intervention. The two specific aims of the project are: 1) To determine if introducing a self-administered Reproductive Life Planning Tool (RLPT) with postpartum mothers during the 2-month WBV will increase the proportion of women receiving a well-woman primary care health visit by 6 months postpartum; and if introducing a self-administered Reproductive Life Planning Tool (RLPT) will increase utilization rates of contraception by 6 months postpartum. 2) To assess patient-, provider-, and systems-level barriers and facilitators to integrating a self-administered Reproductive Life Planning Tool (RLPT) designed to facilitate referral of postpartum women for primary well-woman care in the context of a pediatric clinic. The investigators hypothesize that exposure to a self-administered RLPT combined with a conversation with a pediatrician during a 2-month WBV will increase use of well-woman primary health care during the postpartum period as well as receipt of contraception, by 6-months postpartum. If successful, the results of this study have great potential to inform clinical and public health practice to increase women's use of health care and contraception in the postpartum period.

Conditions

Postpartum Period; Contraception Behavior; Women's Health; Primary Health Care

Keywords

Postpartum; Contraception

Outcome Measures

Primary Outcomes (2)

• Change in receipt of primary care services - self report

  Change in receipt of primary care services will be ascertained by self-report on the 2-month and 6-month Postpartum interview.

  2-months and 6-months Postpartum (baseline and 4-months from baseline data collection)

• Change in receipt of primary care services - EMR review

  Change in receipt of primary care services will be ascertained by electronic medical record review at 2-months and 6-months Postpartum. Evidence of a visit from either source (self-report or EMR review) will be counted as receipt.

  2-months and 6-months Postpartum (baseline and 4-months from baseline data collection)

Secondary Outcomes (3)

• Contraception utilization

  2-months and 6-months Postpartum (baseline and 4-months from baseline data collection)

• Participant feasibility and acceptability

  The last half of Year 2

• Provider feasibility and acceptability

  The last half of Year 2

Study Arms (2)

Control

NO INTERVENTION

This group will not receive the RLPT.

Intervention

EXPERIMENTAL

This group will receive the RLPT.

Behavioral: RLPT

Interventions

RLPT BEHAVIORAL

The Reproductive Life Plan Tool (RLPT) will be self-administered. Pediatricians will use the RLPT to assess women's need for well-woman primary care.

Intervention

Eligibility Criteria

• Age: 15 Years - 49 Years
• Gender Eligibility Details: Postpartum women
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64)

You may qualify if:

• Postpartum women 15-49 years
• Present with infant for a 2-month WBV at the UIC CYC or PCAC
• Receive healthcare at UIC
• Speak English or Spanish

You may not qualify if:

• Pregnant
• \< 15 years or \> 49 years of age
• Receive healthcare outside the UIC system
• Do not speak English or Spanish

Sponsors & Collaborators

• University of Illinois at Chicago: lead
• Agency for Healthcare Research and Quality (AHRQ): collaborator

Study Sites (1)

University of Illinois at Chicago

Chicago, Illinois, 60612, United States

Location

Related Publications (2)

• Caskey RN, Olender SE, Zocchi A, Bergo CJ, Uesugi KH, Haider S, Handler AS. Addressing Women's Health Care Needs During Pediatric Care. Womens Health Rep (New Rochelle). 2021 Jul 9;2(1):227-234. doi: 10.1089/whr.2021.0016. eCollection 2021.

  PMID: 34318292 DERIVED

• Yonemoto N, Nagai S, Mori R. Schedules for home visits in the early postpartum period. Cochrane Database Syst Rev. 2021 Jul 21;7(7):CD009326. doi: 10.1002/14651858.CD009326.pub4.

  PMID: 34286512 DERIVED

MeSH Terms

Conditions

Contraception Behavior

Condition Hierarchy (Ancestors)

Reproductive Behavior; Behavior

Study Officials

• Rachel Caskey, MD, MAPP

  University of Illinois at Chicago

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Masking Details: Because we are studying health behaviors, we cannot share the specific aims of the study with control group participants as this could bias behavior. The control group participants will be told that this is a study monitoring women's general health care experiences at UIH.
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Chief, Division of Academic Internal Medicine

Model Details: The control group will be enrolled during phase 1 (first 4 months) prior to the introduction of the intervention. After enrollment of the control group, a 6-week washout period prior to phase 2 (intervention) will ensure women are not enrolled into both arms of the study.

Study Record Dates

• First Submitted: February 7, 2018
• First Posted: February 28, 2018
• Study Start: January 24, 2018
• Primary Completion: September 29, 2019
• Study Completion: September 29, 2019
• Last Updated: October 24, 2019

Record last verified: 2019-10

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)